OPHTHAMIZE Trademark

Trademark Overview

On Tuesday, August 21, 2018, a trademark application was filed for OPHTHAMIZE with the United States Patent and Trademark Office. The USPTO has given the OPHTHAMIZE trademark a serial number of 88086574. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 8, 2021. This trademark is owned by Macregen, Inc.. The OPHTHAMIZE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical drugs for the treatment and prevention of eye diseases
ophthamize

General Information

Serial Number88086574
Word MarkOPHTHAMIZE
Filing DateTuesday, August 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements

Goods and Servicespharmaceutical drugs for the treatment and prevention of eye diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMacregen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35245
Party NameMacregen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95136

Trademark Events

Event DateEvent Description
Monday, November 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 1, 2021EXTENSION 4 GRANTED
Monday, March 1, 2021EXTENSION 4 FILED
Monday, March 1, 2021TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020EXTENSION 3 GRANTED
Tuesday, September 1, 2020EXTENSION 3 FILED
Tuesday, September 1, 2020TEAS EXTENSION RECEIVED
Tuesday, March 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020EXTENSION 2 GRANTED
Friday, March 6, 2020EXTENSION 2 FILED
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Monday, September 9, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2019EXTENSION 1 GRANTED
Monday, September 9, 2019EXTENSION 1 FILED
Monday, September 9, 2019TEAS EXTENSION RECEIVED
Tuesday, April 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 26, 2018ASSIGNED TO LIE
Friday, December 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 7, 2018EXAMINER'S AMENDMENT ENTERED
Friday, December 7, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 7, 2018EXAMINERS AMENDMENT E-MAILED
Friday, December 7, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, December 6, 2018ASSIGNED TO EXAMINER
Wednesday, August 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 24, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

ophthamize diseases prevention treatment drugs pharmaceutical